Share on StockTwits

CombiMatrix (NASDAQ:CBMX) CFO Scott R. Burell purchased 1,000 shares of the stock in a transaction dated Wednesday, August 27th. The shares were purchased at an average cost of $2.04 per share, for a total transaction of $2,040.00. Following the transaction, the chief financial officer now directly owns 1,912 shares of the company’s stock, valued at approximately $3,900. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link.

Separately, analysts at Zacks reiterated an “outperform” rating on shares of CombiMatrix in a research note on Friday, August 8th. They now have a $3.50 price target on the stock.

CombiMatrix (NASDAQ:CBMX) traded down 3.90% on Thursday, hitting $1.97. 167,793 shares of the company’s stock traded hands. CombiMatrix has a 1-year low of $1.91 and a 1-year high of $4.44. The stock has a 50-day moving average of $2.1 and a 200-day moving average of $2.49. The company’s market cap is $21.8 million.

CombiMatrix Corporation is a molecular diagnostics company. The Company operates in the field of genetic analysis and molecular diagnostics through its wholly owned subsidiary, CombiMatrix Molecular Diagnostics, Inc located in Irvine, California.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.